Turmeric May Induce Cell Death in Esophageal Cancer Sans Apoptosis
Turmeric, or curcumin (diferuloylmethane), may be a favorable agent for the prevention and treatment of esophageal cancer, according to researchers at the Cork Cancer Research Center and Mercy University Hospital in Cork, Ireland. The authors noted that turmeric was able to induce cell death by a mechanism that is not reliant on apoptosis induction.
Turmeric, or curcumin (diferuloylmethane), may be a favorable agent for the prevention and treatment of esophageal cancer, according to researchers at the Cork Cancer Research Center and Mercy University Hospital in Cork, Ireland. The authors noted that turmeric was able to induce cell death by a mechanism that is not reliant on apoptosis induction.
They examined the effects of curcumin on esophageal cancer cell lines, focusing on mitotic catastrophe, apoptosis, and autophagy. They found that curcumin-responsive cells accumulated poly-ubiquitinated proteins and cyclin B, which was consistent with a disturbance of the ubiquitin-proteasome system.
"This effect...may be responsible for the mitotic disturbances and consequent cytotoxicity of [curcumin]," they wrote (Br J Cancer online, October 6, 2009).
Progress Reported in Advanced Esophageal Cancer
June 7th 2010Meeting podcast: Listen to nationally regarded GI cancer specialist and clinical researcher, Peter C. Enzinger, MD, Assistant Professor of Medicine, Dana-Farber Cancer Institute, discuss new developments and trends in the management of esophageal cancer.
